» Journals » Oncogene

Oncogene

Oncogene is a renowned scientific journal that focuses on the molecular and cellular aspects of cancer research. It publishes cutting-edge studies exploring the mechanisms underlying oncogenesis, tumor progression, and metastasis. With a multidisciplinary approach, Oncogene provides a platform for researchers to share their findings on oncogenes, tumor suppressor genes, signaling pathways, and therapeutic strategies, contributing to the advancement of cancer biology and the development of novel treatments.

Details
Abbr. Oncogene
Start 1987
End Continuing
Frequency 50 no. a year, <2007->
p-ISSN 0950-9232
e-ISSN 1476-5594
Country United Kingdom
Language English
Metrics
h-index / Ranks: 100 370
SJR / Ranks: 922 2334
CiteScore / Ranks: 573 15.60
JIF / Ranks: 681 8.0
Recent Articles
1.
Bai X, Duan T, Shao J, Zhang Y, Xing G, Wang J, et al.
Oncogene . 2025 Mar; PMID: 40089640
Chemoresistance poses a significant challenge in colorectal cancer (CRC) treatment. However, the mechanisms underlying chemoresistance remain unclear. CBX3 promoted proliferation and metastasis in CRC. However, the role and mechanism of...
2.
Greiner D, Xue Q, Waddell T, Kurudza E, Chaudhary P, Belote R, et al.
Oncogene . 2025 Mar; PMID: 40082557
Approximately half of melanoma patients relapse or fail to respond to current standards of care, highlighting the need for new treatment options. Engineering T-cells with chimeric antigen receptors (CARs) has...
3.
Xie Y, Zhao R, Zheng Y, Li Y, Wu F, Lei Y, et al.
Oncogene . 2025 Mar; PMID: 40082556
Acute myeloid leukemia (AML) represents the most prevalent malignancy within the hematologic system, characterized by refractory relapses and a scarcity of effective treatment options. Karyopherin subunit beta-1 (KPNB1) is a...
4.
Wang B, Zhang S, Guo Y, Gao W, Wu H, Wang J, et al.
Oncogene . 2025 Mar; PMID: 40082555
Chromobox homolog 2 (CBX2), a component of the polycomb repressive complex 1, is overexpressed in various cancers, but its specific role in colorectal cancer (CRC) is not fully understood. This...
5.
Miyauchi S, Roy S, Boutros N, Sharabi A
Oncogene . 2025 Mar; PMID: 40074885
Head and neck cancer is the seventh most common cancer worldwide and its development is associated with viral infection. Human papillomavirus (HPV) is the major cause of oropharyngeal cancer and...
6.
Zhou J, Wang J, Yang L, Fu T, Li H, Shan Y, et al.
Oncogene . 2025 Mar; PMID: 40074884
Hepatoblastoma (HB) is a rare but predominant liver cancer in children, with few treatment choices in advanced stages. YWHAE is closely related to several human diseases and acts as a...
7.
Zhu J, Wang L, Nie X, Ou S, Shen J, Zhang S, et al.
Oncogene . 2025 Mar; PMID: 40069332
Sorafenib, a first-line targeted drug for advanced hepatocellular carcinoma (HCC), has limited clinical application due to intrinsic/acquired resistance. In this study, we have identified the RNA-binding protein RBMS3 as a...
8.
Huang J, Luo S, Shen J, Lee M, Chen R, Ma S, et al.
Oncogene . 2025 Mar; PMID: 40057606
Disrupted cellular polarity (DCP) is a hallmark of solid cancer, the malignant disease of epithelial tissues, which occupies ~90% of all human cancers. DCP has been identified to affect not...
9.
Bai M, Xu P, Cheng R, Li N, Cao S, Guo Q, et al.
Oncogene . 2025 Mar; PMID: 40057605
Hypoxia is an established hallmark of tumorigenesis. HIF-1α activation may be the prime driver of adaptive regulation of tumor cells reacting to hypoxic conditions of the tumor microenvironment. Here, we...
10.
McGrail K, Granado-Martinez P, Orsenigo R, Caratu G, Nieto P, Heyn H, et al.
Oncogene . 2025 Mar; PMID: 40057604
The mechanisms behind UVB-initiated, neonatal-specific melanoma linked to BRAF are not well understood, particularly regarding its role in growth arrest. We found that, beyond mutations, neonatal UV irradiation or Lkb1...